Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:08 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableUnknownINTERVENTIONAL

Prolonged Protocol of Early Follicular or Mid Luteal Phase

ClinicalTrials.gov · NCT04522479 · Registry updated: 2020-08-21

Condition / research focus: IVF
Sponsor: Second Affiliated Hospital of Wenzhou Medical University
Countries with listed sites: China
Registry dates and results: Start: 2020-05-13. Completion: 2024-05-13 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Change the injection time of long acting GnRH-a (other)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

"Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles"

ClinicalTrials.gov · NCT04458454 · Registry updated: 2020-07-07

Condition / research focus: Infertility; Reproductive Techniques, Assisted; Oocyte Maturation
Sponsor: D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
Countries with listed sites: Russia
Registry dates and results: Start: 2019-12-02. Completion: 2020-02-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Relaxin ELISA Kit (diagnostic_test)

Where the study takes place — 1 listed sites

DOOttResearch
Saint Petersburg, Russia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response

ClinicalTrials.gov · NCT03373149 · Registry updated: 2020-05-27

Condition / research focus: Infertility, Female
Sponsor: Riyadh Fertility and Reproductive Health center
Countries with listed sites: Egypt
Registry dates and results: Start: 2017-11-29. Completion: 2020-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Growth hormone/HPuFSH/GnRH antagonist (drug)
HPuFSH/GnRH antagonist (drug)

Where the study takes place — 1 listed sites

Riyadh Fertility and Reproductive Health center
Giza, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Portal Hypertension and Systemic Endothelial Function

ClinicalTrials.gov · NCT02850692 · Registry updated: 2020-05-26

Condition / research focus: Cystic Fibrosis; Portal Hypertension
Sponsor: Hopital Foch
Countries with listed sites: France
Registry dates and results: Start: 2016-04-18. Completion: 2021-12 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

measure of endothelial function (other)
Blood sample (biological)
Hepatic elastography (other)
Injected abdominal CT (diagnostic_test)

Where the study takes place — 1 listed sites

Hopital Foch
Suresnes, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH)

ClinicalTrials.gov · NCT03687606 · Registry updated: 2020-04-08

Condition / research focus: Isolated Hypogonadotropic Hypogonadism; Kallmann Syndrome; Infertility
Sponsor: Tongji Hospital
Countries with listed sites: China
Registry dates and results: Start: 2018-10-18. Completion: 2025-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human Chorionic Gonadotropin (drug) — also listed as: hCG
human menopausal gonadotropin (drug) — also listed as: hMG

Where the study takes place — 1 listed sites

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Injection of Hormone to Enhance Implantation in Embryo Transfer After IVF

ClinicalTrials.gov · NCT01986374 · Registry updated: 2020-03-19

Condition / research focus: Infertility
Sponsor: Servy Massey Fertility Insititute
Countries with listed sites: United States
Registry dates and results: Start: 2013-06. Completion: 2016-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HCG is introduced (drug) — also listed as: Improve results of IVF and embryo transfer

Where the study takes place — 1 listed sites

Servy Massey Fertility Insititute
Atlanta, Georgia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)

ClinicalTrials.gov · NCT01094496 · Registry updated: 2020-02-13

Condition / research focus: Bladder Cancer
Sponsor: Celldex Therapeutics
Countries with listed sites: United States
Registry dates and results: Start: 2010-04. Completion: 2011-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

CDX-1307 Vaccine Regimen (biological)
Chemotherapy (drug)

Where the study takes place — 17 listed sites

BCG Oncology, PC
Phoenix, Arizona, United States
Site recruitment: Not reported
University of California - San Diego
La Jolla, California, United States
Site recruitment: Not reported
University of Southern California Norris Comprehensive Cancer Center LA-USC Medical Center
Los Angeles, California, United States
Site recruitment: Not reported
University of Colorado Cancer Center
Aurora, Colorado, United States
Site recruitment: Not reported
University of Florida
Gainesville, Florida, United States
Site recruitment: Not reported
Moffitt Cancer Center
Tampa, Florida, United States
Site recruitment: Not reported
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Site recruitment: Not reported
University of Kentucky Markey Cancer Center Clinical Research Organization
Lexington, Kentucky, United States
Site recruitment: Not reported
University of Maryland Greenebaum Cancer Center
Baltimore, Maryland, United States
Site recruitment: Not reported
Henry Ford Health System
Detroit, Michigan, United States
Site recruitment: Not reported
Washington University School of Medicine
St Louis, Missouri, United States
Site recruitment: Not reported
Roswell Park Cancer Center
Buffalo, New York, United States
Site recruitment: Not reported
Weill Cornell Medical College
New York, New York, United States
Site recruitment: Not reported
University of Rochester
Rochester, New York, United States
Site recruitment: Not reported
SUNY Upstate Medical University
Syracuse, New York, United States
Site recruitment: Not reported
Syracuse VA Medical Center
Syracuse, New York, United States
Site recruitment: Not reported
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Luteal Phase Support in Insemination Cycles

ClinicalTrials.gov · NCT03115307 · Registry updated: 2020-01-27

Condition / research focus: Infertility, Female
Sponsor: Tampere University Hospital
Countries with listed sites: Finland
Registry dates and results: Start: 2017-01. Completion: 2019-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Triptorelin (drug)

Where the study takes place — 1 listed sites

Tampere University Hospital
Tampere, Finland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2WithdrawnINTERVENTIONAL

ITT-5 Mechanisms of Spermatogenesis in Man

ClinicalTrials.gov · NCT02147964 · Registry updated: 2019-12-18

Condition / research focus: Gonadotropin Deficiency
Sponsor: University of Washington
Countries with listed sites: United States
Registry dates and results: Start: 2019-06. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Testosterone 1% Gel (drug) — also listed as: T gel, Testosterone gel, AndroGel
Acyline (drug)
Dutasteride (drug) — also listed as: Avodart
Ketoconazole (drug)
HCG (drug) — also listed as: Human chorionic gonadotropin (HCG)
placebo dutasteride (drug)
placebo ketoconazole (drug)

Where the study takes place — 1 listed sites

University of Washington Medical Center (Health Sciences)
Seattle, Washington, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

IVM for Patients With Low Ovarian Response. Does it Improve IVFoutcomes and Does it Improve the Following IVF Cycle?

ClinicalTrials.gov · NCT02498210 · Registry updated: 2019-11-27

Condition / research focus: Infertility Female
Sponsor: Sheba Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2016-10. Completion: 2020-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

In Vitro Maturation Procedure (other)

Where the study takes place — 1 listed sites

Sheba Medical Center
Kiryat Ono, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

IVM Versus Standard IVF in Infertile Patients Diagnosed With PCOS

ClinicalTrials.gov · NCT03463772 · Registry updated: 2019-10-29

Condition / research focus: PCOS
Sponsor: Jie Qiao
Countries with listed sites: China
Registry dates and results: Start: 2018-03-16. Completion: 2020-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

standard IVF (procedure)
In vitro maturation (drug) — also listed as: IVM

Where the study takes place — 1 listed sites

Peking University third Hospital
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)

ClinicalTrials.gov · NCT01969201 · Registry updated: 2019-10-09

Condition / research focus: Infertility
Sponsor: IBSA Institut Biochimique SA
Countries with listed sites: Belgium · Italy · Spain · Switzerland · Turkey (Türkiye) · United Kingdom
Registry dates and results: Start: 2014-01. Completion: 2017-08 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Urofollitrophin (drug) — also listed as: human derived follicle stimulation hormone
Follitrophin alpha (drug) — also listed as: Recombinant follicle stimulation hormone

Where the study takes place — 16 listed sites

UCL- Cliniques Universitaires Saint Luc
Brussels, Belgium
Site recruitment: Not reported
Universitair Ziekenhuis Brussel
Brussels, Belgium
Site recruitment: Not reported
Spedali Civili di Brescia
Brescia, Italy
Site recruitment: Not reported
Fondazione Ca'Granda, Osp Maggiore Policlinico
Milan, Italy
Site recruitment: Not reported
IRCCS San Raffaele
Milan, Italy
Site recruitment: Not reported
Università degli Studi di Napoli 'Federico II'
Naples, Italy
Site recruitment: Not reported
Azienda Ospedaliera Di Reggio Emilia
Reggio Emilia, Italy
Site recruitment: Not reported
Clinica IVI Alicante
Alicante, Spain
Site recruitment: Not reported
Institut Universitari Dexeus
Barcelona, Spain
Site recruitment: Not reported
Ginefiv Clínica de Fertilidad
Madrid, Spain
Site recruitment: Not reported
Instituto Valenciano de Infertilidad (IVI)
Seville, Spain
Site recruitment: Not reported
Universitäts-Frauenklinik
Basel, Canton of Basel-City, Switzerland
Site recruitment: Not reported
Universitätsklinik für Frauenheilkunde
Bern, Canton of Bern, Switzerland
Site recruitment: Not reported
Prof. Bülent Urman
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported
Ege University
Izmir, Turkey (Türkiye)
Site recruitment: Not reported
Midland Fertility Services
Aldridge, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

ClinicalTrials.gov · NCT02919800 · Registry updated: 2019-09-30

Condition / research focus: Hemophilia A or B With Inhibitors
Sponsor: OPKO Health, Inc.
Countries with listed sites: Israel
Registry dates and results: Start: 2017-01-22. Completion: 2018-02-21 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

MOD-5014 (biological)
MOD-5014 Placebo (other)

Where the study takes place — 1 listed sites

TASMC
Tel Aviv, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Metformin in Intracytoplasmic Sperm Injection Cycles

ClinicalTrials.gov · NCT03088631 · Registry updated: 2019-09-17

Condition / research focus: Intracytoplasmatic Sperm Injection
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2017-03-01. Completion: 2019-04-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Metformin (drug)
Placebo (other)

Where the study takes place — 1 listed sites

Women Health Hospital - Assiut university
Asyut, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

hCG-activated PBMC-therapy in RIF Patients

ClinicalTrials.gov · NCT03267797 · Registry updated: 2019-08-26

Condition / research focus: Recurrent Implantation Failure
Sponsor: SCARM Institute, Tabriz, Iran
Countries with listed sites: Iran
Registry dates and results: Start: 2017-10-07. Completion: 2019-07-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Peripheral Blood Monouclear Cell (other) — also listed as: PBMC
Phosphate Baffer Saline (other) — also listed as: PBS

Where the study takes place — 1 listed sites

Valiasr Hospital
Tabriz, Iran
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

The Safety and Pharmacokinetics of Primapur and Gonal-f

ClinicalTrials.gov · NCT03857230 · Registry updated: 2019-08-13

Condition / research focus: Area Under Curve; Pharmacokinetics; Absorption
Sponsor: IVFarma LLC
Countries with listed sites: Russia
Registry dates and results: Start: 2015-10-29. Completion: 2016-05-10 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Follitropin alfa (Primapur) (drug) — also listed as: Follitropin alpha, Follitropin
Follitropin alfa (Gonal-F) (drug) — also listed as: Follitropin alpha, Follitropin

Where the study takes place — 1 listed sites

O.M. Filatov Municipal Clinical Hospital N 15
Moscow, Russia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)

ClinicalTrials.gov · NCT02145247 · Registry updated: 2019-08-12

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2014-05. Completion: 2018-01 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (drug) — also listed as: Re-combinant human choriogonadotropin

Where the study takes place — 1 listed sites

University of California, San Diego
La Jolla, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Early Luteal Progesterone Profile in IVF Patients Triggered With hCG

ClinicalTrials.gov · NCT03174691 · Registry updated: 2019-08-06

Condition / research focus: Infertility
Sponsor: Vietnam National University
Countries with listed sites: Vietnam
Registry dates and results: Start: 2017-06-07. Completion: 2017-08-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood collection (diagnostic_test)

Where the study takes place — 1 listed sites

My Duc Hospital
Ho Chi Minh City, Vietnam
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Long-term Endogenous Androgen Priming in Bologna Criteria Poor Responder Patients - A Pilot Study

ClinicalTrials.gov · NCT03447184 · Registry updated: 2019-07-05

Condition / research focus: Poor Ovarian Response
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2018-03-26. Completion: 2019-03-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Androgen priming (drug) — also listed as: low dose hCG and aromatase inhibitor priming

Where the study takes place — 1 listed sites

Lan N Vuong
Ho Chi Minh City, Vietnam
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles

ClinicalTrials.gov · NCT04008966 · Registry updated: 2019-07-05

Condition / research focus: Assisted Reproduction
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2016-07-20. Completion: 2019-07-01 (may be estimated). No results posted in this registry response.

Products and interventions (9)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

combined oral contaraceptive pills (drug) — also listed as: Gynera
recombinant FSH (drug)
Urinaru gonadotropin (drug)
GnRH antagonist (drug) — also listed as: Cetrotide
Human chorionic gonadotropin (drug)
GnRH agonist (drug) — also listed as: triptorelin
Ovum pick up (procedure)
Embryo transfer (procedure)
natural Progesterone (drug) — also listed as: Prontogest

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:08 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableUnknownINTERVENTIONAL

Prolonged Protocol of Early Follicular or Mid Luteal Phase

ClinicalTrials.gov · NCT04522479 · Registry updated: 2020-08-21

Condition / research focus: IVF
Sponsor: Second Affiliated Hospital of Wenzhou Medical University
Countries with listed sites: China
Registry dates and results: Start: 2020-05-13. Completion: 2024-05-13 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Change the injection time of long acting GnRH-a (other)

Where the study takes place — 1 listed sites

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

"Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles"

ClinicalTrials.gov · NCT04458454 · Registry updated: 2020-07-07

Condition / research focus: Infertility; Reproductive Techniques, Assisted; Oocyte Maturation
Sponsor: D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
Countries with listed sites: Russia
Registry dates and results: Start: 2019-12-02. Completion: 2020-02-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Relaxin ELISA Kit (diagnostic_test)

Where the study takes place — 1 listed sites

DOOttResearch
Saint Petersburg, Russia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response

ClinicalTrials.gov · NCT03373149 · Registry updated: 2020-05-27

Condition / research focus: Infertility, Female
Sponsor: Riyadh Fertility and Reproductive Health center
Countries with listed sites: Egypt
Registry dates and results: Start: 2017-11-29. Completion: 2020-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Growth hormone/HPuFSH/GnRH antagonist (drug)
HPuFSH/GnRH antagonist (drug)

Where the study takes place — 1 listed sites

Riyadh Fertility and Reproductive Health center
Giza, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Portal Hypertension and Systemic Endothelial Function

ClinicalTrials.gov · NCT02850692 · Registry updated: 2020-05-26

Condition / research focus: Cystic Fibrosis; Portal Hypertension
Sponsor: Hopital Foch
Countries with listed sites: France
Registry dates and results: Start: 2016-04-18. Completion: 2021-12 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

measure of endothelial function (other)
Blood sample (biological)
Hepatic elastography (other)
Injected abdominal CT (diagnostic_test)

Where the study takes place — 1 listed sites

Hopital Foch
Suresnes, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH)

ClinicalTrials.gov · NCT03687606 · Registry updated: 2020-04-08

Condition / research focus: Isolated Hypogonadotropic Hypogonadism; Kallmann Syndrome; Infertility
Sponsor: Tongji Hospital
Countries with listed sites: China
Registry dates and results: Start: 2018-10-18. Completion: 2025-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human Chorionic Gonadotropin (drug) — also listed as: hCG
human menopausal gonadotropin (drug) — also listed as: hMG

Where the study takes place — 1 listed sites

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Injection of Hormone to Enhance Implantation in Embryo Transfer After IVF

ClinicalTrials.gov · NCT01986374 · Registry updated: 2020-03-19

Condition / research focus: Infertility
Sponsor: Servy Massey Fertility Insititute
Countries with listed sites: United States
Registry dates and results: Start: 2013-06. Completion: 2016-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HCG is introduced (drug) — also listed as: Improve results of IVF and embryo transfer

Where the study takes place — 1 listed sites

Servy Massey Fertility Insititute
Atlanta, Georgia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)

ClinicalTrials.gov · NCT01094496 · Registry updated: 2020-02-13

Condition / research focus: Bladder Cancer
Sponsor: Celldex Therapeutics
Countries with listed sites: United States
Registry dates and results: Start: 2010-04. Completion: 2011-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

CDX-1307 Vaccine Regimen (biological)
Chemotherapy (drug)

Where the study takes place — 17 listed sites

BCG Oncology, PC
Phoenix, Arizona, United States
Site recruitment: Not reported
University of California - San Diego
La Jolla, California, United States
Site recruitment: Not reported
University of Southern California Norris Comprehensive Cancer Center LA-USC Medical Center
Los Angeles, California, United States
Site recruitment: Not reported
University of Colorado Cancer Center
Aurora, Colorado, United States
Site recruitment: Not reported
University of Florida
Gainesville, Florida, United States
Site recruitment: Not reported
Moffitt Cancer Center
Tampa, Florida, United States
Site recruitment: Not reported
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Site recruitment: Not reported
University of Kentucky Markey Cancer Center Clinical Research Organization
Lexington, Kentucky, United States
Site recruitment: Not reported
University of Maryland Greenebaum Cancer Center
Baltimore, Maryland, United States
Site recruitment: Not reported
Henry Ford Health System
Detroit, Michigan, United States
Site recruitment: Not reported
Washington University School of Medicine
St Louis, Missouri, United States
Site recruitment: Not reported
Roswell Park Cancer Center
Buffalo, New York, United States
Site recruitment: Not reported
Weill Cornell Medical College
New York, New York, United States
Site recruitment: Not reported
University of Rochester
Rochester, New York, United States
Site recruitment: Not reported
SUNY Upstate Medical University
Syracuse, New York, United States
Site recruitment: Not reported
Syracuse VA Medical Center
Syracuse, New York, United States
Site recruitment: Not reported
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Luteal Phase Support in Insemination Cycles

ClinicalTrials.gov · NCT03115307 · Registry updated: 2020-01-27

Condition / research focus: Infertility, Female
Sponsor: Tampere University Hospital
Countries with listed sites: Finland
Registry dates and results: Start: 2017-01. Completion: 2019-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Triptorelin (drug)

Where the study takes place — 1 listed sites

Tampere University Hospital
Tampere, Finland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2WithdrawnINTERVENTIONAL

ITT-5 Mechanisms of Spermatogenesis in Man

ClinicalTrials.gov · NCT02147964 · Registry updated: 2019-12-18

Condition / research focus: Gonadotropin Deficiency
Sponsor: University of Washington
Countries with listed sites: United States
Registry dates and results: Start: 2019-06. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Testosterone 1% Gel (drug) — also listed as: T gel, Testosterone gel, AndroGel
Acyline (drug)
Dutasteride (drug) — also listed as: Avodart
Ketoconazole (drug)
HCG (drug) — also listed as: Human chorionic gonadotropin (HCG)
placebo dutasteride (drug)
placebo ketoconazole (drug)

Where the study takes place — 1 listed sites

University of Washington Medical Center (Health Sciences)
Seattle, Washington, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

IVM for Patients With Low Ovarian Response. Does it Improve IVFoutcomes and Does it Improve the Following IVF Cycle?

ClinicalTrials.gov · NCT02498210 · Registry updated: 2019-11-27

Condition / research focus: Infertility Female
Sponsor: Sheba Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2016-10. Completion: 2020-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

In Vitro Maturation Procedure (other)

Where the study takes place — 1 listed sites

Sheba Medical Center
Kiryat Ono, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

IVM Versus Standard IVF in Infertile Patients Diagnosed With PCOS

ClinicalTrials.gov · NCT03463772 · Registry updated: 2019-10-29

Condition / research focus: PCOS
Sponsor: Jie Qiao
Countries with listed sites: China
Registry dates and results: Start: 2018-03-16. Completion: 2020-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

standard IVF (procedure)
In vitro maturation (drug) — also listed as: IVM

Where the study takes place — 1 listed sites

Peking University third Hospital
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)

ClinicalTrials.gov · NCT01969201 · Registry updated: 2019-10-09

Condition / research focus: Infertility
Sponsor: IBSA Institut Biochimique SA
Countries with listed sites: Belgium · Italy · Spain · Switzerland · Turkey (Türkiye) · United Kingdom
Registry dates and results: Start: 2014-01. Completion: 2017-08 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Urofollitrophin (drug) — also listed as: human derived follicle stimulation hormone
Follitrophin alpha (drug) — also listed as: Recombinant follicle stimulation hormone

Where the study takes place — 16 listed sites

UCL- Cliniques Universitaires Saint Luc
Brussels, Belgium
Site recruitment: Not reported
Universitair Ziekenhuis Brussel
Brussels, Belgium
Site recruitment: Not reported
Spedali Civili di Brescia
Brescia, Italy
Site recruitment: Not reported
Fondazione Ca'Granda, Osp Maggiore Policlinico
Milan, Italy
Site recruitment: Not reported
IRCCS San Raffaele
Milan, Italy
Site recruitment: Not reported
Università degli Studi di Napoli 'Federico II'
Naples, Italy
Site recruitment: Not reported
Azienda Ospedaliera Di Reggio Emilia
Reggio Emilia, Italy
Site recruitment: Not reported
Clinica IVI Alicante
Alicante, Spain
Site recruitment: Not reported
Institut Universitari Dexeus
Barcelona, Spain
Site recruitment: Not reported
Ginefiv Clínica de Fertilidad
Madrid, Spain
Site recruitment: Not reported
Instituto Valenciano de Infertilidad (IVI)
Seville, Spain
Site recruitment: Not reported
Universitäts-Frauenklinik
Basel, Canton of Basel-City, Switzerland
Site recruitment: Not reported
Universitätsklinik für Frauenheilkunde
Bern, Canton of Bern, Switzerland
Site recruitment: Not reported
Prof. Bülent Urman
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported
Ege University
Izmir, Turkey (Türkiye)
Site recruitment: Not reported
Midland Fertility Services
Aldridge, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

ClinicalTrials.gov · NCT02919800 · Registry updated: 2019-09-30

Condition / research focus: Hemophilia A or B With Inhibitors
Sponsor: OPKO Health, Inc.
Countries with listed sites: Israel
Registry dates and results: Start: 2017-01-22. Completion: 2018-02-21 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

MOD-5014 (biological)
MOD-5014 Placebo (other)

Where the study takes place — 1 listed sites

TASMC
Tel Aviv, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Metformin in Intracytoplasmic Sperm Injection Cycles

ClinicalTrials.gov · NCT03088631 · Registry updated: 2019-09-17

Condition / research focus: Intracytoplasmatic Sperm Injection
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2017-03-01. Completion: 2019-04-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Metformin (drug)
Placebo (other)

Where the study takes place — 1 listed sites

Women Health Hospital - Assiut university
Asyut, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

hCG-activated PBMC-therapy in RIF Patients

ClinicalTrials.gov · NCT03267797 · Registry updated: 2019-08-26

Condition / research focus: Recurrent Implantation Failure
Sponsor: SCARM Institute, Tabriz, Iran
Countries with listed sites: Iran
Registry dates and results: Start: 2017-10-07. Completion: 2019-07-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Peripheral Blood Monouclear Cell (other) — also listed as: PBMC
Phosphate Baffer Saline (other) — also listed as: PBS

Where the study takes place — 1 listed sites

Valiasr Hospital
Tabriz, Iran
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

The Safety and Pharmacokinetics of Primapur and Gonal-f

ClinicalTrials.gov · NCT03857230 · Registry updated: 2019-08-13

Condition / research focus: Area Under Curve; Pharmacokinetics; Absorption
Sponsor: IVFarma LLC
Countries with listed sites: Russia
Registry dates and results: Start: 2015-10-29. Completion: 2016-05-10 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Follitropin alfa (Primapur) (drug) — also listed as: Follitropin alpha, Follitropin
Follitropin alfa (Gonal-F) (drug) — also listed as: Follitropin alpha, Follitropin

Where the study takes place — 1 listed sites

O.M. Filatov Municipal Clinical Hospital N 15
Moscow, Russia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)

ClinicalTrials.gov · NCT02145247 · Registry updated: 2019-08-12

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2014-05. Completion: 2018-01 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (drug) — also listed as: Re-combinant human choriogonadotropin

Where the study takes place — 1 listed sites

University of California, San Diego
La Jolla, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Early Luteal Progesterone Profile in IVF Patients Triggered With hCG

ClinicalTrials.gov · NCT03174691 · Registry updated: 2019-08-06

Condition / research focus: Infertility
Sponsor: Vietnam National University
Countries with listed sites: Vietnam
Registry dates and results: Start: 2017-06-07. Completion: 2017-08-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood collection (diagnostic_test)

Where the study takes place — 1 listed sites

My Duc Hospital
Ho Chi Minh City, Vietnam
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Long-term Endogenous Androgen Priming in Bologna Criteria Poor Responder Patients - A Pilot Study

ClinicalTrials.gov · NCT03447184 · Registry updated: 2019-07-05

Condition / research focus: Poor Ovarian Response
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2018-03-26. Completion: 2019-03-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Androgen priming (drug) — also listed as: low dose hCG and aromatase inhibitor priming

Where the study takes place — 1 listed sites

Lan N Vuong
Ho Chi Minh City, Vietnam
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles

ClinicalTrials.gov · NCT04008966 · Registry updated: 2019-07-05

Condition / research focus: Assisted Reproduction
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2016-07-20. Completion: 2019-07-01 (may be estimated). No results posted in this registry response.

Products and interventions (9)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

combined oral contaraceptive pills (drug) — also listed as: Gynera
recombinant FSH (drug)
Urinaru gonadotropin (drug)
GnRH antagonist (drug) — also listed as: Cetrotide
Human chorionic gonadotropin (drug)
GnRH agonist (drug) — also listed as: triptorelin
Ovum pick up (procedure)
Embryo transfer (procedure)
natural Progesterone (drug) — also listed as: Prontogest

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →